Related Experiment Video
Updated: Jun 21, 2026
10:01
Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
Published on: March 12, 2018
Alternative techniques of cardioplegia
T M Yau1, R D Weisel, D A Mickle
1Division of Cardiovascular Surgery, Toronto Hospital, Ontario, Canada.
Circulation
|November 1, 1992
Summary
Different cardioplegia techniques impact myocardial metabolism during cardiac surgery. Warm antegrade cardioplegia maximized oxygen consumption, while cold cardioplegia preserved adenine nucleotides but inhibited mitochondrial function.
Area of Science:
- Cardiology
- Cardiac Surgery
- Biochemistry
Background:
- Normothermic cardioplegia is clinically accepted, but its metabolic effects are not fully understood.
- Limited research exists on the metabolic consequences of various myocardial protection strategies.
Purpose of the Study:
- To compare the metabolic effects of three cardioplegic techniques during coronary artery bypass graft surgery.
- To assess myocardial metabolic recovery following different cardioplegia methods.
Main Methods:
- A randomized clinical trial involving 74 patients undergoing coronary artery bypass graft surgery.
- Patients received normothermic antegrade, normothermic retrograde, or intermittent cold antegrade blood cardioplegia.
- Measurements included myocardial oxygen consumption, lactate production, adenine nucleotides, and cardiac creatine kinase isoenzyme (CK-MB) release.
Main Results:
- Warm antegrade cardioplegia maximized myocardial oxygen consumption.
- Warm retrograde cardioplegia led to the highest anaerobic lactate production.
- Cold cardioplegia resulted in adenine nucleotide accumulation and inhibited mitochondrial function, while warm antegrade cardioplegia caused washout of adenosine triphosphate (ATP) precursors.
Conclusions:
- Intermittent cold cardioplegia preserved adenine nucleotides but impaired mitochondrial function.
- Warm antegrade cardioplegia demonstrated higher myocardial oxygen consumption.
- No significant differences in clinical outcomes or postoperative CK-MB release were observed across the groups.
More Related Videos
Related Concept Videos
01:25Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...